Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 558.60M | 526.50M | 429.80M | 256.70M | 128.40M | 94.40M |
Gross Profit | 207.00M | 172.70M | 90.20M | 28.40M | 22.90M | 20.40M |
EBITDA | -200.60M | -183.90M | -209.80M | -282.60M | -229.90M | -119.10M |
Net Income | -217.30M | -202.20M | -236.90M | -297.80M | -241.30M | -122.30M |
Balance Sheet | ||||||
Total Assets | 1.86B | 1.85B | 1.63B | 1.69B | 1.51B | 828.70M |
Cash, Cash Equivalents and Short-Term Investments | 639.80M | 376.00M | 264.50M | 1.03B | 1.07B | 577.40M |
Total Debt | 123.70M | 107.20M | 43.10M | 35.20M | 22.30M | 0.00 |
Total Liabilities | 1.31B | 1.26B | 924.40M | 823.90M | 522.30M | 287.70M |
Stockholders Equity | 545.50M | 593.40M | 708.90M | 866.80M | 988.20M | 541.00M |
Cash Flow | ||||||
Free Cash Flow | -38.00M | -20.80M | -128.30M | -173.10M | -154.00M | -96.10M |
Operating Cash Flow | -28.80M | -11.40M | -119.10M | -163.00M | -144.60M | -91.70M |
Investing Cash Flow | -30.60M | 40.60M | 88.70M | 181.10M | -804.80M | 50.10M |
Financing Cash Flow | 94.20M | 87.70M | 15.40M | 3.60M | 649.60M | 341.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $2.19B | 17.66 | 16.03% | ― | 25.88% | 9.45% | |
70 Outperform | $2.11B | 40.41 | 17.95% | ― | 98.66% | ― | |
69 Neutral | $1.09B | 14.93 | 8.75% | 5.03% | 19.05% | 40.69% | |
68 Neutral | $1.65B | 13.82 | 28.75% | 1.12% | 20.89% | 3.25% | |
68 Neutral | $16.93B | 11.67 | 9.79% | 3.89% | 11.83% | -7.56% | |
65 Neutral | $1.63B | 22.48 | 5.31% | 3.43% | 11.40% | 73.12% | |
52 Neutral | $3.09B | ― | -35.57% | ― | 21.44% | 2.99% |
Lemonade, Inc. announced the terms of its reinsurance program effective from July 1, 2025, to June 30, 2026, involving a reduction in the ceded proportion of its quota share reinsurance from approximately 55% to 20%. This strategic move is expected to maintain a variable ceding commission rate similar to previous agreements, potentially impacting the company’s financial strategy and stakeholder interests.
The most recent analyst rating on (LMND) stock is a Hold with a $44.00 price target. To see the full list of analyst forecasts on Lemonade stock, see the LMND Stock Forecast page.
On June 4, 2025, Lemonade held its annual meeting of stockholders, with 68.41% of the voting power represented. During the meeting, Shai Wininger and Dr. Samer Haj-Yehia were elected as Class II Directors until 2028. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025 was ratified, and the compensation of the company’s named executive officers was approved on a non-binding basis.
The most recent analyst rating on (LMND) stock is a Hold with a $44.00 price target. To see the full list of analyst forecasts on Lemonade stock, see the LMND Stock Forecast page.